首页> 外文期刊>Patient Preference and Adherence >A new pen device for injection of recombinant human growth hormone: a convenience, functionality and usability evaluation study
【24h】

A new pen device for injection of recombinant human growth hormone: a convenience, functionality and usability evaluation study

机译:一种用于注射重组人生长激素的新型笔装置:便利性,功能性和可用性评估研究

获取原文
       

摘要

Purpose: Adherence to recombinant human growth hormone (r-hGH) is critical to growth and other outcomes in patients with growth disorders, but the requirement for daily injections means that ease of use is an important factor. This study assessed the perceived ease of use and functionality of the prototype of a reusable pen injector (pen device) for r-hGH that incorporates several advanced features. Participants and methods: Semi-structured 60-minute qualitative interviews were conducted in 5 countries with 57 health care professionals (HCPs) and 30 patients with GH deficiency/caregivers administering r-hGH to patients, including children. HCPs had to be responsible for training in the use of r-hGH pen devices and to see ≥4 r-hGH patients/caregivers per month. Patients/caregivers had to have experience with r-hGH administration for at least 6 months. Results: Thirty-seven (65%) of HCPs described the pen device as “simple” or “easy” to use. The aluminum body was generally perceived as attractive, high quality and comfortable to hold and operate. The ease of preparation and use made it suitable for both children and adults. The ability to dial back the r-hGH dose, if entered incorrectly, was mentioned as a major benefit, because other devices need several user steps to reset. Patients/caregivers felt the pen device was easy to use and the injection-feedback features reassured them that the full dose had been given. Overall, 40 (70%) HCPs and 16 (52%) patients/caregivers were likely to recommend or request the pen device. Moreover, patients/caregivers rated the pen device higher than their current reusable pens and almost equal to the leading disposable device for ease of learning, preparation, administration and ease of use. Conclusion: The prototype pen device successfully met its design objectives and was very well accepted by HCPs and patients/caregivers for its ease of use, appearance and functionality.
机译:目的:坚持重组人生长激素(r-hGH)对于生长障碍患者的生长和其他结局至关重要,但是每天注射的需求意味着易用性是重要因素。这项研究评估了用于r-hGH的可重复使用的笔式注射器(笔装置)的原型的易用性和功能性,该原型具有几个高级功能。参与者和方法:在5个国家/地区进行了半结构化的60分钟定性访谈,其中包括57名医疗保健专业人员(HCP)和30名患有GH缺乏症/照顾者的患者,他们对包括儿童在内的患者进行了r-hGH治疗。 HCP必须负责使用r-hGH笔设备的培训,并且每月要看≥4名r-hGH患者/护理人员。患者/护理人员必须具有至少6个月的r-hGH管理经验。结果:37个(65%)的HCP将笔设备描述为“简单”或“易于使用”。铝制车身通常被认为具有吸引力,高品质且握持和操作舒适。易于制备和使用,使其适合儿童和成人。提到回拨r-hGH剂量的功能(如果输入错误)是一个主要好处,因为其他设备需要几个用户步骤来重置。患者/护理人员认为笔式设备易于使用,并且注射反馈功能使他们放心,已经服用了全部剂量。总体而言,有40位(70%)的HCP和16位(52%)的患者/护理人员可能会推荐或要求使用笔设备。此外,患者/护理人员对笔式设备的评价高于其当前可重复使用的笔,并且几乎等于领先的一次性设备,以易于学习,准备,管理和使用。结论:原型笔设备成功实现了其设计目标,并且因其易用性,外观和功能而被HCP和患者/护理人员很好地接受。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号